Recent

% | $
Quotes you view appear here for quick access.

công ty Aastrom Biosciences Message Board

  • drrobhale drrobhale Jun 25, 2005 6:26 PM Flag

    What Happened ?

    ASTM has had previous clinical trials, why were the trials not completed?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • CB-I is (was) for use with umbilical cord blood. The market in this area is still relatively small and the testing time consuming. For example the phase 1 study done at Duke university with CB-I spent one year transfusing patients with the output of CB-I, and another 4 plus years of follow up. I believe ASTM has stated that the follow up for bone repair will be 18 months.

      SC-I/II, and Dendricell were about treating cancer. This is a field that not only kills people, it kills companies trying to find cancer cures. To test a cancer cure you spend a lot of time and money, and when the study is complete, you perform an arcane statistical analysis. If you're lucky your analysis tells you that that the treatment helps a little bit. You then take your analysis to the FDA and try to convince them that the statistical analysis is valid.

      With bone repair, they seem to have a situation where you don't need to have a team of statistician debate whether or not the treatment was a success. Or at least this was the case in the data that was recently released. In addition the studies are cheap, relatively quick to perform, and the potential market is very large.

 
ASTM
0.00(0.00%)